✦ LIBER ✦

A Phase I trial of h-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma

✍ Scribed by C. Casey Cunningham; Jon T. Holmlund; Richard S. Geary; T. Jesse Kwoh; Andrew Dorr; Joseph F. Johnston; Brett Monia; John Nemunaitis

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 84 KB
Volume: 92
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20010901)92:5<1265::aid-cncr1447>3.0.co;2-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of cisplatin in hyperton

A phase I trial of cisplatin in hypertonic saline and escalating doses of 5-fluorouracil by continuous intravenous infusion in patients with advanced malignancies

✍ Leonard Saltz; David Kelsen 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB 👁 1 views

Phase I/II trial of paclitaxel by 1-hour

Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma

✍ John D. Hainsworth; Howard A. Burris III; Joan B. Erland; Lisa H. Morrissey; Ant 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

## BACKGROUND. The combination of paclitaxel and carboplatin is widely used in the treatment of patients with advanced nonsmall cell lung carcinoma. In this Phase I/II study the authors evaluated the feasibility, toxicity, and efficacy of adding a third active antineoplastic agent, gemcitabine, to